Evaluation and Management of Primary Hyperaldosteronism
Overview
Authors
Affiliations
Primary hyperaldosteronism is an important and increasingly prevalent cause of hypertension that is characterized by unregulated aldosterone excess. More than 90% of primary hyperaldosteronism cases are attributable to either idiopathic adrenal hyperplasia or aldosterone-producing adenomas. The approach to the diagnosis of primary hyperaldosteronism should be step-wise, starting with screening of at-risk populations, confirmatory testing for positively screened patients, and subtype classification in order to direct surgical or medical management. Based on current guidelines, subtype classification of primary hyperaldosteronism should be determined with both imaging and adrenal vein sampling (AVS), reserving deferment of AVS for a selective subset of patients.
Araujo-Castro M, Ruiz-Sanchez J, Parra Ramirez P, Martin Rojas-Marcos P, Aguilera-Saborido A, Gomez Cerezo J Endocrine. 2024; 85(2):532-544.
PMID: 38507182 DOI: 10.1007/s12020-024-03773-9.
Yin X, Ai K, Luo J, Liu W, Ma X, Zhou L Front Endocrinol (Lausanne). 2024; 15:1291775.
PMID: 38419957 PMC: 10899670. DOI: 10.3389/fendo.2024.1291775.
Popoviciu M, Paduraru L, Nutas R, Ujoc A, Yahya G, Metwally K Int J Mol Sci. 2023; 24(16).
PMID: 37628857 PMC: 10454882. DOI: 10.3390/ijms241612676.
Cardiovascular Remodeling in Chronic Mineralocorticoid Excess.
Bhattad P, Roumia M Cureus. 2023; 15(6):e40753.
PMID: 37485117 PMC: 10361634. DOI: 10.7759/cureus.40753.
Acute psychotic episode inaugurating a primary hyperaldosteronism: a case report.
El Bouchalli W, El Mir K, El Jabiry S, Berrimi M Pan Afr Med J. 2023; 43:103.
PMID: 36699970 PMC: 9834794. DOI: 10.11604/pamj.2022.43.103.32944.